Rebuttal to

Please copy the URL and add it into your RSS Feed Reader.

Thromb Haemost 2008; 99(05): 969
DOI: 10.1160/TH08-03-0198

Letters to the Editor

Schattauer GmbH

Rebuttal to "Aspirin response variability assessed with the PFA-100 device" by Reny et al.

Marilena Crescente

¹Research Laboratories, "John Paul II" Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
Augusto Di Castelnuovo

¹Research Laboratories, "John Paul II" Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
Licia Iacoviello

¹Research Laboratories, "John Paul II" Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
Giovanni de Gaetano

¹Research Laboratories, "John Paul II" Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
Chiara Cerletti

¹Research Laboratories, "John Paul II" Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Received 29 March 2008

Accepted 01 April 2008

Publication Date:
30 November 2017 (online)

References
1 Snoep JD, Hovens MM, Eikenboom JC. et al. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 1593-1599.

Reference Link Ris
Crossref PubMed Search in Google Scholar
2 Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002; 324: 71-86.

Reference Link Ris
Crossref PubMed Search in Google Scholar
3 Reny JL, Quéré I, de Moerloose P. et al. Aspirin response variability assessed with the PFA-100 device. Thromb Haemost 2008; 99: 968-969.

Reference Link Ris
Thieme Connect PubMed Search in Google Scholar